The effects of adenosine A(1) and A(2) agonists on spontaneous central
sleep apneas in rats have been examined by simultaneously monitoring
sleep and respiration in freely moving unanesthetized animals. Intrape
ritoneal administration of 1.0 mg/kg of the A(1) receptor agonist R(-)
N-6-L-(2-phenyl-isopropyl)adenosine (L-PIA) and 150 and 300 mu g/kg of
hyl)phenethylamino-5'-N-ethylcarboxamido-adenosine hydrochloride (CGS
21680), a selective A(2) agonist, decreased the apnea index (AI) duri
ng sleep. Within a sleep period, AI increased over time in both contro
l and drug-treated animals. For both agonists, doses effective in redu
cing AI also significantly reduced sleep efficiency.